Purchase Order 75N98019P03329
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and related products, to provide a NextSeq 2000 sequencing system. The potential value of the contract is $290,700.00. There was no set-aside designation for this award. Illumina has previously received prime contract awards from federal agencies like the National...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of genetic sequencing systems and related products, for the delivery of an Illumina NextSeq 550 Sequencing System. The potential value of the award is $224,400.00. No set-aside provisions were used. The award was made under a special notice solicitation for an Illumina HiSeq 2500 Sequencer. Illumina has...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $178,500.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, for the purchase of a NextSeq 500 sequencing system. This award supports the NIH's research and diagnostic needs, as Illumina has provided a range of sequencing systems and consumables to HHS, the Centers for Disease Control and Prevention, the Department of...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $224,400.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The award is for the provision of a NextSeq 550 Sequencing System with a trade-in of a HiSeq 500 system. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NEXTSEQ 1000 SEQUENCING SYSTEM, with a potential value of $142,100.00. The contract does not have a set-aside designation and is expected to be completed by April 14, 2025. Illumina has...
- This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and analytical products. The $24,728.01 contract is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and...
- This $149,519.97 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and bioinformatics support. The contract does...
- The Department of Health and Human Services National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a $210,784.04 firm fixed-price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, and bioinformatics support. This award is not...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $147,003.32 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $197,925.00 firm fixed price purchase order for an Illumina NextSeq Sequencing System to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The purchase order was not set aside for any specific business size or type. The award is intended to support the agency's mission by providing a sequencing platform that can increase data output...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a firm fixed-price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, to provide a NextSeq 550 sequencing system and associated support plan. The total potential value of the contract is $392,924.00, with a completion date of September 29, 2025. The contract was awarded on a sole-source basis, with no set-aside designation, under the authority of FAR Subpart 13.106-1(b) for procurements where only one responsible source can fulfill the requirement. Illumina has previously received prime federal contract awards from agencies such as the NIH, CDC, USDA, and VA to provide a range of sequencing systems and related products and services to support genomic research and diagnostics.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NextSeq 550 System or the Silver Support Plan. | NIH-OLAO-OD3-NOI-5460055 | Department of Health and Human Services National Institutes of Health Office of Acquisition Management and Policy | Special Notice 1/1 | 9/17/19, 2:16 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $238.4k | 9/21/19 |